FDA chief questions protections on drug rebates, stocks fall
(Reuters) - U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers should remain protected by federal law, sparking new concerns on Wall Street over efforts to curb drug pricing.
from Reuters: Health News https://reut.rs/2FHRrCG
http://bit.ly/2zwRqiM